HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prospects for therapeutic tolerance in humans.

AbstractPURPOSE OF REVIEW:
To provide an overview of recent advances and future possibilities for therapeutic tolerance.
RECENT FINDINGS:
Allograft survival despite complete immunosuppressant withdrawal has been demonstrated in selected renal-transplant recipients with haematopoietic chimerism. Early clinical trials of mesenchymal stromal cell therapy have shown promising results in several autoimmune diseases. Regulatory T cells show potential benefit in graft versus host disease, although challenges to ex-vivo expansion remain. Targeted modulation of T-cell function in vivo with monoclonal antibodies has shown beneficial effects in phase II/III trials of multiple sclerosis (alemtuzumab) and type I diabetes mellitus (teplizumab, otelixizumab). Emerging data from animal models suggest an important role for the commensal microbiome in the maintenance and disruption of immune tolerance with parallels in human studies.
SUMMARY:
After years of slow progress, recent research has reduced the translational gap between animal models and clinical therapeutic tolerance. Early detection of autoimmunity, potentially at preclinical stages, offers a window of opportunity for tolerogenic therapy. Reliable biomarkers of tolerance are urgently needed to provide objective measurements of the effectiveness of tolerogenic therapies, and to allow intelligent immunosuppressant withdrawal in patients whose autoimmune disease is stable.
VIDEO ABSTRACT AVAILABLE:
See the Video Supplementary Digital Content 1 (http://links.lww.com/COR/A8).
AuthorsKenneth F Baker, John D Isaacs
JournalCurrent opinion in rheumatology (Curr Opin Rheumatol) Vol. 26 Issue 2 Pg. 219-27 (Mar 2014) ISSN: 1531-6963 [Electronic] United States
PMID24378931 (Publication Type: Journal Article, Review)
Chemical References
  • Biomarkers
Topics
  • Allografts
  • Animals
  • Autoimmune Diseases (immunology, therapy)
  • Biomarkers (analysis)
  • Cell- and Tissue-Based Therapy
  • Graft Survival
  • Humans
  • Immune Tolerance
  • Immunosuppression Therapy (methods, trends)
  • Microbiota (immunology)
  • T-Lymphocytes (immunology)
  • Translational Research, Biomedical
  • Transplantation Chimera (immunology)
  • Transplantation Immunology

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: